Any way you look at it, Moderna (NASDAQ: MRNA) is on a roll. Here's why Moderna just booked another $3 billion in vaccine orders and no one seemed to care. Moderna announced last week that the U.S. government was buying another 200 million doses of its COVID-19 vaccine.
Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting